1. Home
  2. XENE vs CVI Comparison

XENE vs CVI Comparison

Compare XENE & CVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • CVI
  • Stock Information
  • Founded
  • XENE 1996
  • CVI 1906
  • Country
  • XENE Canada
  • CVI United States
  • Employees
  • XENE N/A
  • CVI N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • CVI Integrated oil Companies
  • Sector
  • XENE Health Care
  • CVI Energy
  • Exchange
  • XENE Nasdaq
  • CVI Nasdaq
  • Market Cap
  • XENE 3.2B
  • CVI 3.6B
  • IPO Year
  • XENE 2014
  • CVI 2007
  • Fundamental
  • Price
  • XENE $43.87
  • CVI $34.46
  • Analyst Decision
  • XENE Strong Buy
  • CVI Strong Sell
  • Analyst Count
  • XENE 11
  • CVI 3
  • Target Price
  • XENE $53.55
  • CVI $26.67
  • AVG Volume (30 Days)
  • XENE 782.5K
  • CVI 1.1M
  • Earning Date
  • XENE 11-03-2025
  • CVI 10-29-2025
  • Dividend Yield
  • XENE N/A
  • CVI N/A
  • EPS Growth
  • XENE N/A
  • CVI 140.58
  • EPS
  • XENE N/A
  • CVI 1.65
  • Revenue
  • XENE $7,500,000.00
  • CVI $7,299,000,000.00
  • Revenue This Year
  • XENE N/A
  • CVI N/A
  • Revenue Next Year
  • XENE $207.88
  • CVI $1.72
  • P/E Ratio
  • XENE N/A
  • CVI $20.70
  • Revenue Growth
  • XENE N/A
  • CVI N/A
  • 52 Week Low
  • XENE $26.74
  • CVI $15.10
  • 52 Week High
  • XENE $44.23
  • CVI $41.67
  • Technical
  • Relative Strength Index (RSI)
  • XENE 68.37
  • CVI 41.36
  • Support Level
  • XENE $39.09
  • CVI $35.44
  • Resistance Level
  • XENE $42.31
  • CVI $36.48
  • Average True Range (ATR)
  • XENE 1.48
  • CVI 1.36
  • MACD
  • XENE 0.31
  • CVI -0.38
  • Stochastic Oscillator
  • XENE 99.40
  • CVI 25.32

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

Share on Social Networks: